MAPT and Alzheimer disease: Overall, casesclassified as AD by the CSF biomarker profile, had significantly higherlevels of AT8-positive tau aggregates and a strong trend for highertotal tau (CI95 = −2.62, 54.65) and Aβ (CI95 = −2.83, 71.54) aggregate levels.